Quidel | QDEL - Current Liabilities


Quidel reported $966.1M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Agilent USD 2.35B 455M Sep/2025
Avanos Medical USD 147.9M 13.3M Sep/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Cerus USD 88.43M 4.08M Sep/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Danaher USD 6.81B 483M Dec/2025
Exact Sciences USD 641.15M 56.89M Dec/2025
Haemonetics USD 539.87M 8.45M Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Illumina USD 1.59B 377M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Merit Medical Systems USD 230.48M 4.9M Sep/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Neogen USD 147.05M 850K Sep/2025
OraSure Technologies USD 40.25M 2.1M Sep/2025
Pacific Biosciences Of California USD 63.21M 3.45M Sep/2025
Quidel USD 966.1M 198.2M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
STAAR Surgical USD 61.64M 2.41M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Waters USD 1.24B 11.8M Dec/2025